Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes against high glucose induced shifts in substrate preference and apoptosis.
about
Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes.Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-β-D-glucoside.Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage: a protocol for a systematic review.TXNIP regulates myocardial fatty acid oxidation via miR-33a signalingThe Transcription Profile Unveils the Cardioprotective Effect of Aspalathin against Lipid Toxicity in an In Vitro H9c2 Model.Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.Evaluation of capillary electrophoresis for the analysis of rooibos and honeybush tea phenolics.Diabetes-Related Cardiac Dysfunction.Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs.Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling.Minimising variation in aspalathin content of aqueous green rooibos extract: optimising extraction and identifying critical material attributes.A dose-dependent effect of dimethyl sulfoxide on lipid content, cell viability and oxidative stress in 3T3-L1 adipocytes
P2860
Q33749642-2D16BDEE-DFC9-4570-ACE2-36C2FE0E8852Q33892587-2EC93F5D-77BA-41BB-A088-625785380363Q36370627-8C31C8B5-8B53-4BDB-810D-8CE3D8B6E630Q37139649-1FBBA41B-A7FB-438F-A90F-518E477D5DA9Q38718497-B6E46AC5-A2E0-4C9A-8B0F-E7991CCE7689Q38720805-4F945E5C-4DFF-44E4-8E1D-11F9455F1839Q38845086-2175DEF5-3DA6-4AB5-890E-87997778D03DQ39127715-7A1FC842-711A-474C-814E-D1E3ED89F5DCQ39420123-0E340E4C-D4E9-46B2-BED2-C2A6D3BAA816Q46185931-212ABE3F-7A3C-475D-A978-F10475A106E0Q46309786-63924761-A967-4193-B57A-490B4994200FQ48292470-41FD6BBA-754C-4827-A5B2-8F0D32D1D22BQ58584735-F41EF9ED-AD78-4291-B149-8D3EA0B63AE1
P2860
Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes against high glucose induced shifts in substrate preference and apoptosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Aspalathin, a dihydrochalcone ...... rate preference and apoptosis.
@en
Aspalathin, a dihydrochalcone ...... rate preference and apoptosis.
@nl
type
label
Aspalathin, a dihydrochalcone ...... rate preference and apoptosis.
@en
Aspalathin, a dihydrochalcone ...... rate preference and apoptosis.
@nl
prefLabel
Aspalathin, a dihydrochalcone ...... rate preference and apoptosis.
@en
Aspalathin, a dihydrochalcone ...... rate preference and apoptosis.
@nl
P2093
P2860
P50
P356
P1476
Aspalathin, a dihydrochalcone ...... trate preference and apoptosis
@en
P2093
Christo Muller
Faghri February
Johan Louw
Samira Ghoor
Sithandiwe Mazibuko
P2860
P304
P356
10.1002/MNFR.201500656
P577
2016-02-12T00:00:00Z